Symbols / VRAX Stock $0.22 +35.32% Virax Biolabs Group Limited

Healthcare • Biotechnology • United Kingdom • NCM
VRAX (Stock) Chart
About

Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary diagnostics under the ViraxVet brand. It also provides ViraxImmune, a T cell In vitro diagnostic device and wellness mobile application; and service, such as antibody engineering, custom peptides, protein sequencing, vaccine efficacy testing, immunology lab services, kits and reagents. In addition, the company is involved in research and development activities; and provision of procurement, warehousing, product development, and staffing management services. It serves research organizations, corporations, independent laboratories, large hospital systems and public and private institutions, as well as distributor customers. The company operates in the United Kingdom, the United States, and China. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was founded in 2013 and is headquartered in Lanarkshire, the United Kingdom.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 1.63M
Enterprise Value -1.70M Income -5.64M Sales 2.99K
Book/sh 0.81 Cash/sh 0.53 Dividend Yield —
Payout 0.00% Employees 19 IPO —
P/E — Forward P/E -0.92 PEG —
P/S 546.69 P/B 0.27 P/C —
EV/EBITDA 0.31 EV/Sales -569.13 Quick Ratio 9.89
Current Ratio 11.35 Debt/Eq 10.60 LT Debt/Eq —
EPS (ttm) -1.22 EPS next Y -0.24 EPS Growth —
Revenue Growth -67.50% Earnings — ROA -48.40%
ROE -83.82% ROIC — Gross Margin 0.00%
Oper. Margin -1607.88% Profit Margin 0.00% Shs Outstand 7.42M
Shs Float 5.50M Short Float 0.15% Short Ratio 0.05
Short Interest — 52W High 1.34 52W Low 0.15
Beta 1.71 Avg Volume 224.99K Volume 234.90M
Target Price $1.00 Recom None Prev Close $0.16
Price $0.22 Change 35.32%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$1.00
Mean price target
2. Current target
$0.22
Latest analyst target
3. DCF / Fair value
$-8.58
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.22
Low
$1.00
High
$1.00
Mean
$1.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-09 reit HC Wainwright & Co. Buy → Buy $1
2025-03-31 init HC Wainwright & Co. — → Buy $3
News
RSS: Latest VRAX news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Revenue
0.01
-95.95%
0.16
+1727.11%
0.01
0.00
Operating Revenue
0.01
-95.95%
0.16
+1727.11%
0.01
0.00
Cost Of Revenue
0.06
-43.87%
0.11
+966.18%
0.01
0.00
Reconciled Cost Of Revenue
0.06
-43.87%
0.11
+966.18%
0.01
0.00
Gross Profit
-0.05
-204.90%
0.05
+3806.23%
-0.00
0.00
Operating Expense
6.11
-0.76%
6.16
+7.42%
5.73
+230.59%
1.73
Research And Development
1.78
+13.95%
1.56
-28.33%
2.18
+402.45%
0.43
Selling General And Administration
4.33
-5.76%
4.59
+29.35%
3.55
+173.25%
1.30
Selling And Marketing Expense
—
—
0.03
+92.62%
0.01
General And Administrative Expense
4.33
-5.76%
4.59
+29.35%
3.55
+173.25%
1.30
Other Gand A
4.33
-5.76%
4.59
+29.35%
3.55
+173.25%
1.30
Total Expenses
6.17
-1.49%
6.26
+9.08%
5.74
+231.16%
1.73
Operating Income
-6.16
-0.93%
-6.11
-6.51%
-5.73
-230.67%
-1.73
Total Operating Income As Reported
-6.16
+5.13%
-6.50
-13.32%
-5.73
-230.67%
-1.73
EBITDA
-5.80
+12.21%
-6.61
-21.44%
-5.44
-213.78%
-1.73
Normalized EBITDA
-5.80
+6.70%
-6.22
-14.27%
-5.44
-213.78%
-1.73
Reconciled Depreciation
0.34
+233.07%
0.10
0.00
0.00
EBIT
-6.15
+8.44%
-6.71
-23.33%
-5.44
-213.78%
-1.73
Total Unusual Items
0.00
+100.00%
-0.39
0.00
0.00
Total Unusual Items Excluding Goodwill
0.00
+100.00%
-0.39
0.00
0.00
Special Income Charges
0.00
+100.00%
-0.39
0.00
0.00
Impairment Of Capital Assets
0.00
-100.00%
0.39
0.00
0.00
Net Income
-6.06
+9.98%
-6.73
-23.38%
-5.46
-219.37%
-1.71
Pretax Income
-6.20
+7.94%
-6.74
-23.48%
-5.46
-211.90%
-1.75
Net Non Operating Interest Income Expense
-0.06
-116.46%
-0.03
-73.77%
-0.02
-0.19%
-0.02
Interest Expense Non Operating
0.06
+116.46%
0.03
+73.77%
0.02
+0.19%
0.02
Net Interest Income
-0.06
-116.46%
-0.03
-73.77%
-0.02
-0.19%
-0.02
Interest Expense
0.06
+116.46%
0.03
+73.77%
0.02
+0.19%
0.02
Other Income Expense
0.02
+102.83%
-0.61
-308.67%
0.29
+38674.50%
-0.00
Other Non Operating Income Expenses
0.02
+107.96%
-0.22
-174.28%
0.29
+38674.50%
-0.00
Tax Provision
-0.14
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-6.07
+9.97%
-6.74
-23.48%
-5.46
-211.90%
-1.75
Net Income From Continuing Operation Net Minority Interest
-6.06
+9.98%
-6.73
-23.38%
-5.46
-219.37%
-1.71
Net Income From Continuing And Discontinued Operation
-6.06
+9.98%
-6.73
-23.38%
-5.46
-219.37%
-1.71
Net Income Continuous Operations
-6.07
+9.97%
-6.74
-23.48%
-5.46
-211.90%
-1.75
Minority Interests
0.01
+7.20%
0.01
+1975.46%
0.00
-99.34%
0.04
Normalized Income
-6.06
+4.44%
-6.34
-16.23%
-5.46
-219.37%
-1.71
Net Income Common Stockholders
-6.06
+9.98%
-6.73
-23.38%
-5.46
-219.37%
-1.71
Diluted EPS
-1.62
+51.79%
-3.36
+34.50%
-5.13
-241.46%
-1.50
Basic EPS
-1.62
+51.79%
-3.36
+34.50%
-5.13
-241.46%
-1.50
Basic Average Shares
3.73
+85.92%
2.01
+88.75%
1.06
-6.54%
1.14
Diluted Average Shares
3.73
+85.92%
2.01
+88.75%
1.06
-6.54%
1.14
Diluted NI Availto Com Stockholders
-6.06
+9.98%
-6.73
-23.38%
-5.46
-219.37%
-1.71
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Assets
6.43
+17.19%
5.48
-44.11%
9.81
+20046.22%
0.05
Current Assets
4.89
+11.72%
4.38
-54.53%
9.63
+19679.93%
0.05
Cash Cash Equivalents And Short Term Investments
4.23
+17.82%
3.59
-61.62%
9.35
+42888.32%
0.02
Cash And Cash Equivalents
4.23
+17.82%
3.59
-61.62%
9.35
+42888.32%
0.02
Cash Financial
4.23
+17.82%
3.59
-61.62%
9.35
+42888.32%
0.02
Receivables
0.03
-85.93%
0.22
0.00
0.00
Accounts Receivable
—
—
—
0.00
Gross Accounts Receivable
—
—
—
0.00
Allowance For Doubtful Accounts Receivable
—
—
—
0.00
Taxes Receivable
0.03
-85.93%
0.22
0.00
—
Inventory
0.09
+56.79%
0.06
0.00
-100.00%
0.02
Raw Materials
0.05
0.00
—
—
Work In Process
0.04
0.00
—
—
Finished Goods
0.00
-100.00%
0.06
0.00
-100.00%
0.02
Prepaid Assets
0.54
+5.19%
0.51
+82.18%
0.28
+4592.03%
0.01
Total Non Current Assets
1.53
+38.92%
1.10
+518.67%
0.18
0.00
Net PPE
1.53
+38.92%
1.10
0.00
—
Gross PPE
1.98
+63.70%
1.21
+10768.30%
0.01
—
Accumulated Depreciation
-0.44
-329.01%
-0.10
-828.49%
-0.01
—
Machinery Furniture Equipment
0.07
+14.82%
0.06
+455.03%
0.01
—
Other Properties
1.90
+66.33%
1.15
—
—
Goodwill And Other Intangible Assets
—
0.00
-100.00%
0.18
0.00
Other Intangible Assets
—
—
0.18
—
Total Liabilities Net Minority Interest
0.96
+179.48%
0.35
-62.00%
0.91
-27.06%
1.25
Current Liabilities
0.67
+298.70%
0.17
-81.41%
0.91
-27.06%
1.25
Payables And Accrued Expenses
0.53
+336.13%
0.12
-61.52%
0.31
-74.77%
1.25
Payables
0.40
+593.60%
0.06
-69.94%
0.19
-80.32%
0.98
Accounts Payable
0.06
+22.93%
0.05
-71.46%
0.16
-81.11%
0.85
Current Accrued Expenses
0.13
+100.48%
0.06
-48.26%
0.12
-54.65%
0.27
Pensionand Other Post Retirement Benefit Plans Current
0.06
0.00
-100.00%
0.41
0.00
Total Tax Payable
0.01
-41.95%
0.01
-13.26%
0.01
0.00
Current Debt And Capital Lease Obligation
0.09
+78.21%
0.05
-67.21%
0.15
—
Current Debt
0.03
—
0.15
—
Other Current Borrowings
0.03
—
—
—
Current Capital Lease Obligation
0.05
+10.51%
0.05
0.00
—
Current Deferred Liabilities
—
0.00
-100.00%
0.04
0.00
Current Deferred Revenue
—
0.00
-100.00%
0.04
0.00
Total Non Current Liabilities Net Minority Interest
0.29
+65.33%
0.18
0.00
0.00
Long Term Debt And Capital Lease Obligation
0.29
+65.33%
0.18
0.00
—
Long Term Capital Lease Obligation
0.29
+65.33%
0.18
0.00
—
Stockholders Equity
5.70
+6.14%
5.37
-41.20%
9.13
+1036.45%
-0.97
Common Stock Equity
5.70
+6.14%
5.37
-41.20%
9.13
+1036.45%
-0.97
Capital Stock
0.00
+68.69%
0.00
+65.32%
0.00
+55.86%
0.00
Common Stock
0.00
+68.69%
0.00
+65.32%
0.00
+55.86%
0.00
Share Issued
4.34
+68.69%
2.57
+65.56%
1.55
+36.69%
1.14
Ordinary Shares Number
4.34
+68.69%
2.57
+65.56%
1.55
+36.69%
1.14
Retained Earnings
-24.59
-32.71%
-18.53
-57.09%
-11.79
-86.12%
-6.34
Gains Losses Not Affecting Retained Earnings
30.28
+26.74%
23.89
+14.21%
20.92
+290.18%
5.36
Minority Interest
-0.23
-2.63%
-0.23
-2.51%
-0.22
-0.12%
-0.22
Other Equity Adjustments
30.28
+26.74%
23.89
+14.21%
20.92
—
Total Equity Gross Minority Interest
5.46
+6.29%
5.14
-42.29%
8.90
+844.04%
-1.20
Total Capitalization
5.70
+6.14%
5.37
-41.20%
9.13
+1036.45%
-0.97
Working Capital
4.22
+0.21%
4.21
-51.74%
8.73
+829.13%
-1.20
Invested Capital
5.73
+6.74%
5.37
-42.12%
9.27
+1051.45%
-0.97
Total Debt
0.38
+68.08%
0.22
+53.37%
0.15
—
Capital Lease Obligations
0.34
+53.60%
0.22
0.00
—
Net Tangible Assets
5.70
+6.14%
5.37
-40.02%
8.95
+1018.14%
-0.97
Tangible Book Value
5.70
+6.14%
5.37
-40.02%
8.95
+1018.14%
-0.97
Current Notes Payable
—
0.00
-100.00%
0.15
0.00
Dueto Related Parties Current
0.34
0.00
-100.00%
0.02
-85.92%
0.13
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Cash Flow
-4.56
+26.95%
-6.25
-49.46%
-4.18
-416.61%
-0.81
Cash Flow From Continuing Operating Activities
-4.56
+26.95%
-6.25
-49.46%
-4.18
-416.61%
-0.81
Net Income From Continuing Operations
-6.07
+9.97%
-6.74
-23.48%
-5.46
-211.90%
-1.75
Depreciation Amortization Depletion
0.34
+233.07%
0.10
0.00
0.00
Depreciation
0.34
+233.07%
0.10
0.00
0.00
Depreciation And Amortization
0.34
+233.07%
0.10
0.00
0.00
Other Non Cash Items
0.05
-60.52%
0.12
+477.52%
0.02
-93.25%
0.30
Stock Based Compensation
0.37
-63.90%
1.01
-41.66%
1.73
0.00
Asset Impairment Charge
0.00
-100.00%
0.39
0.00
0.00
Operating Gains Losses
0.12
+1506.65%
-0.01
+97.01%
-0.29
-482513.11%
0.00
Net Foreign Currency Exchange Gain Loss
0.12
+3273.58%
0.00
+3204.50%
0.00
-98.04%
0.01
Change In Working Capital
0.63
+155.86%
-1.12
-514.28%
-0.18
-128.30%
0.64
Change In Receivables
0.22
+200.83%
-0.22
0.00
-100.00%
0.00
Changes In Account Receivables
0.03
0.00
0.00
-100.00%
0.00
Change In Inventory
-0.03
+43.21%
-0.06
-388.21%
0.02
+17214.88%
0.00
Change In Prepaid Assets
-0.03
+88.50%
-0.23
+16.03%
-0.28
-12707.60%
0.00
Change In Payables And Accrued Expense
0.47
+181.58%
-0.57
-1785.95%
0.03
-94.71%
0.64
Change In Payable
0.47
+181.58%
-0.57
-1785.95%
0.03
-94.71%
0.64
Change In Account Payable
0.47
+181.58%
-0.57
-1785.95%
0.03
-94.71%
0.64
Change In Other Working Capital
—
-0.04
-200.00%
0.04
—
Investing Cash Flow
-0.60
+48.14%
-1.16
-552.71%
-0.18
0.00
Cash Flow From Continuing Investing Activities
-0.60
+48.14%
-1.16
-552.71%
-0.18
0.00
Net PPE Purchase And Sale
-0.60
+36.60%
-0.95
0.00
0.00
Purchase Of PPE
-0.60
+36.60%
-0.95
0.00
0.00
Capital Expenditure
-0.60
+48.14%
-1.16
-552.71%
-0.18
—
Net Intangibles Purchase And Sale
0.00
+100.00%
-0.21
-18.81%
-0.18
0.00
Purchase Of Intangibles
0.00
+100.00%
-0.21
-18.81%
-0.18
0.00
Financing Cash Flow
5.81
+252.34%
1.65
-87.96%
13.69
+1583.33%
0.81
Cash Flow From Continuing Financing Activities
5.81
+252.34%
1.65
-87.96%
13.69
+1583.33%
0.81
Net Issuance Payments Of Debt
-0.11
+47.76%
-0.21
-241.04%
0.15
+46.25%
0.10
Issuance Of Debt
0.00
0.00
-100.00%
0.49
+387.50%
0.10
Repayment Of Debt
-0.11
+47.76%
-0.21
+39.55%
-0.34
0.00
Long Term Debt Payments
-0.11
-91.17%
-0.06
0.00
—
Net Long Term Debt Issuance
-0.11
-91.17%
-0.06
0.00
—
Short Term Debt Issuance
0.00
0.00
-100.00%
0.49
+387.50%
0.10
Short Term Debt Payments
0.00
+100.00%
-0.15
+56.07%
-0.34
0.00
Net Short Term Debt Issuance
0.00
+100.00%
-0.15
-202.50%
0.15
+46.25%
0.10
Net Common Stock Issuance
5.13
+2191432.48%
0.00
-100.00%
13.65
+2527.79%
0.52
Proceeds From Stock Option Exercised
0.79
-57.98%
1.87
0.00
0.00
Net Other Financing Charges
—
-0.02
+83.61%
-0.11
-157.67%
0.19
Changes In Cash
0.64
+111.10%
-5.76
-161.77%
9.33
+225553.74%
0.00
Beginning Cash Position
3.59
-61.62%
9.35
+42888.32%
0.02
+23.47%
0.02
End Cash Position
4.23
+17.82%
3.59
-61.62%
9.35
+42888.32%
0.02
Free Cash Flow
-5.17
+30.28%
-7.41
-70.06%
-4.36
-438.66%
-0.81
Interest Paid Supplemental Data
0.08
+1193.46%
0.01
-60.54%
0.02
0.00
Income Tax Paid Supplemental Data
—
0.00
0.00
0.00
Common Stock Issuance
5.13
+2191432.48%
0.00
-100.00%
13.65
+2527.79%
0.52
Issuance Of Capital Stock
5.13
+2191432.48%
0.00
-100.00%
13.65
+2527.79%
0.52
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category